Rebuttal: Questioning the validity of 'anatomy of an epidemic' (part 1)

Affiliations

Comment

William M Glazer. Behav Healthc. 2011 Oct.

. 2011 Oct;31(7):42, 44-5.

No abstract available

Comment on

Transforming our thinking about psychiatric medications.
Ashcraft L, Anthony B. Ashcraft L, et al. Behav Healthc. 2011 Jul-Aug;31(5):12-5. Behav Healthc. 2011. PMID: 21877488 No abstract available.
Transforming our thinking about psychiatric medications (part II). Interview by Lori Ashcraft and Bill Anthony.
Whitaker R. Whitaker R. Behav Healthc. 2011 Sep;31(6):8-11. Behav Healthc. 2011. PMID: 22026106 No abstract available.

Rebuttal: Questioning the validity of 'anatomy of an epidemic' (part II).
Glazer WM. Glazer WM. Behav Healthc. 2011 Nov-Dec;31(8):34-7. Behav Healthc. 2011. PMID: 22283087 No abstract available.
Transforming our thinking about psychiatric medications (part II). Interview by Lori Ashcraft and Bill Anthony.
Whitaker R. Whitaker R. Behav Healthc. 2011 Sep;31(6):8-11. Behav Healthc. 2011. PMID: 22026106 No abstract available.
[Side effects or predictor of the therapy success? Psychotropic drugs as fattener].
[No authors listed] [No authors listed] MMW Fortschr Med. 2004 Jan 15;146(1-2):8. MMW Fortschr Med. 2004. PMID: 18441570 German. No abstract available.
[Psychotropic drugs].
Müller-Spahn F. Müller-Spahn F. Ther Umsch. 1999 Dec;56(12):719-25. doi: 10.1024/0040-5930.56.12.719. Ther Umsch. 1999. PMID: 10638279 Review. German.
[Unwanted effects of psychotropic drugs--selected results from a 10-year multicenter project monitoring drugs in psychiatry].
Grohmann R, Schmidt LG, Antretter K, Rüther E. Grohmann R, et al. Internist (Berl). 1990 Jul;31(7):468-74. Internist (Berl). 1990. PMID: 1975570 Review. German. No abstract available.